Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

TADAWUL/4009 stock hub

TADAWUL/4009 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TADAWUL/4009is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.2B

Saudi Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TADAWUL/4009

In the news

Latest news · TADAWUL/4009

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.6

P25 15.3P50 18.4P75 19.8

Trailing P/E19

P25 16.2P50 19.4P75 30.1

ROEn/a

P25 9.3P50 15.6P75 21.4

ROIC5.2

P25 7P50 12P75 21

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TADAWUL/4009 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

SAR

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Saudi Arabia
Country code	SA
Employees	4,220
Enterprise value	SAR 5.8B
Exchange	Saudi Stock Exchange
Financial currency	SAR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	SA141H01UKH9
Last refreshed	2026-05-10
Market cap	SAR 3.2B
Price	SAR 34.98
Price currency	SAR
Rev Per Employee	742,684.11x
Sector	Healthcare
Sic	8060
Symbol	tadawul/4009
Website	https://saudigermanhealth.com/en

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.26%
EV Earnings	34.38x
EV/EBIT	24.12x
EV/EBITDA	12.33x
EV/FCF	70.5x
EV/Sales	1.84x
FCF yield	2.56%
Forward P/E	18.58x
P/B ratio	1.65x
P/E ratio	19.01x
P/S ratio	1.02x
PE Ratio10 Y	76.05x
PE Ratio3 Y	156.19x
PE Ratio5 Y	128.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.06%
EBITDA Margin	14.83%
FCF margin	2.61%
Gross margin	37.58%
Gross Profit	SAR 1.2B
Gross Profit Growth	4.6%
Gross Profit Growth Q	169.78%
Gross Profit Growth3 Y	17.15%
Gross Profit Growth5 Y	16.96%
Net Income	SAR 167.4M
Net Income Growth	-57.94%
Net Income Growth Q	-83.95%
Net Income Growth Years	4%
Net Income Growth3 Y	16.9%
Net Income Growth5 Y	18.09%
Pretax Margin	6.08%
Profit Margin	5.34%
Profit Per Employee	SAR 39,679
Profitable Years	14
Roa5y	3.42
Roe5y	8.71
ROIC	5.21
Roic5y	4.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.27%
Cagr1y	-50.47%
Cagr3y	-4.61%
Cagr5y	-1.7%
Div CAGR3	-37%
Div CAGR5	-24.21%
EPS Growth	-57.91
EPS Growth Q	-83.91
EPS Growth Years	4
EPS Growth3 Y	16.93
EPS Growth5 Y	18.11
FCF Growth	-77.85%
FCF Growth Q	20.61%
OCF Growth	-37.4%
OCF Growth Q	-2.68%
OCF Growth10 Y	5.87%
OCF Growth3 Y	46.24%
Revenue Growth	7.06x
Revenue Growth Q	4.29x
Revenue Growth Quarters	19x
Revenue Growth Years	7x
Revenue Growth3 Y	11.25x
Revenue Growth5 Y	12.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	SAR 26.3M
Debt	SAR 2.5B
Debt EBITDA	SAR 5.29
Debt Equity	SAR 1.32
Debt FCF	SAR 31.15
Equity	SAR 1.9B
Interest Coverage	1.31
Net Cash	SAR -2.5B
Net Cash By Market Cap	SAR -79.05
Net Debt EBITDA	SAR 5.42
Net Debt Equity	SAR 1.31
Net Debt FCF	SAR 30.82
Tangible Book Value	SAR 1.8B
Tangible Book Value Per Share	SAR 19.72
WACC	5.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.07%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	SAR 0.5
Dividend Years	1
Dividend Yield	1.43%
Last Dividend	SAR 0.5
Payout Ratio	27.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-47.65%
1Y total return	-50.44%
200-day SMA	43.37
3Y total return	-13.2%
50-day SMA	34.91
50-day SMA vs 200-day SMA	50under200
5Y total return	-8.23%
All Time High	134.4
All Time High Change	-73.97%
All Time High Date	2024-02-07
All Time Low	23.88
All Time Low Change	46.48%
All Time Low Date	2019-11-05
ATR	1.16
Beta	-0
Beta1y	0.26
Beta2y	0.57
Ch YTD	7.43
High	35.16
High52	71.4
High52 Date	2025-05-07
High52ch	-51.01%
Low	34.28
Low52	28.66
Low52 Date	2026-03-03
Low52ch	22.05%
Ma50ch	0.2%
Price vs 200-day SMA	-19.34%
RSI	43.37
RSI Monthly	36.62
RSI Weekly	0
Sharpe ratio	-1.8x
Sortino ratio	-2.32
Total Return	1.5%
Tr YTD	7.43
Tr1m	-5.56%
Tr1w	-5.25%
Tr3m	2.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SAR 252.5M
Operating Income Growth	-40.56
Operating Income Growth Q	-69.85
Operating Income Growth3 Y	11.62
Operating Income Growth5 Y	20.22
Operating margin	8.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,810,333%
Net Borrowing	14,540,527
Shares Insiders	0.97%
Shares Institutions	4.7%
Shares Out	92,040,000
Shares Qo Q	-0.29%
Shares Yo Y	-0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SAR 81.7M
Average Volume	1,043,219.25x
Bv Per Share	20.34
CAPEX	SAR -455.2M
Ch10y	-52.57
Ch1m	-5.56
Ch1w	-5.25
Ch1y	-50.87
Ch3m	2.88
Ch3y	-13.95
Ch5y	-9.02
Ch6m	-22.47
Change	1.69%
Change From Open	1.69
Close	34.4
Days Gap	0
Depreciation Amortization	212,255,916
Dollar Volume	48,220,034.9
Earnings Date	2026-05-14
EBIT	SAR 252.5M
EBITDA	SAR 464.8M
EPS	SAR 1.82
F Score	3
FCF	SAR 81.7M
FCF EV Yield	1.42x
FCF Per Share	SAR 0.89
Financing CF	-233,982,021
Fiscal Year End	December
Founded	1,988
Graham Number	28.86692
Graham Upside	-17.48
Income Tax	SAR 15.7M
Investing CF	-557,743,856
Is Primary Listing	1
Last Earnings Date	2025-11-05
Last Report Date	2026-03-31
Lynch Fair Value	SAR 32.94
Lynch Upside	-5.84
Ma150	38.88
Ma150ch	-10.03%
Ma20	37.25
Ma20ch	-6.09%
Net CF	-258,048,521
Next Earnings Date	2026-05-14
Open	34.4
P FCF Ratio	38.99
P OCF Ratio	5.93
Payment Date	2025-07-23
Position In Range	79.55
Price Date	2026-05-07
Price EBITDA	SAR 6.85
Ptbv Ratio	1.75
Relative Volume	1.32x
Revenue	3,134,126,953x
Tax By Revenue	0.5x
Tax Rate	8.22%
Tr6m	-22.47%
Volume	1,378,503

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TADAWUL/4009 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$0.50 annual per share

Payout ratio

+27.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-24.2%

0 consecutive years of growth

Total shareholder yield

+1.5%

Dividend yield + buyback yield combined

Performance

TADAWUL/4009 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TADAWUL/4009?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.7%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

TADAWUL/4009 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.4

Neutral momentum band

Price vs 200-day MA

-19.3%

50/200-day relationship not available

Beta (5Y)

-0.00

Less volatile than the market

Sharpe ratio

-1.80

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TADAWUL/4009

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tadawul/4009 stock rating?

tadawul/4009 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tadawul/4009 analysis?

The full report lives at /stocks/tadawul/4009/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tadawul/4009?

The latest report frames tadawul/4009 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tadawul/4009 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.